Clinical TrialUnknown status

CYP2D6 and the pharmacokinetics of ibogaine

This clinical trial (n=15) evaluated the safety and efficacy of the intervention for opioid dependence opioid dependence.

Target Enrollment
15 participants
Study Type
observational
Design
Non-randomized, triple Blind

Detailed Description

Approved

Study Arms & Interventions

Experimental Arm

experimental

Participants

Inclusion Criteria

  • Placebo

Exclusion Criteria

  • Yes

Study Details

  • Status
    Unknown status
  • Type
    observational
  • Design
    Non-randomizedtriple Blind
  • Target Enrollment15 participants
  • Timeline
    Start: 2013-05-01
    End: 2013-07-01

Locations

Unknown facility — Australia

Your Library